A randomized clinical trial evaluating the immunomodulatory effect of convalescent plasma on COVID-19-related cytokine storm

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

(2020) Dawei Wang et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

(2020) Nanshan Chen et al.   LANCET

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

(2020) Zhe Xu et al.   Lancet Respiratory Medicine

Dramatic improvement after tocilizumab of severe COVID ‐19 in a child with sickle cell disease and acute chest syndrome

(2020) Marie‐Hélène Odièvre et al.   AMERICAN JOURNAL OF HEMATOLOGY

Treatment of COVID-19 Patients with Convalescent Plasma

(2020) Eric Salazar et al.   AMERICAN JOURNAL OF PATHOLOGY

Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report

(2020) J.-M. Michot et al.   ANNALS OF ONCOLOGY

Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China

(2020) Zhongliang Wang et al.   CLINICAL INFECTIOUS DISEASES

Clinical and immunological features of severe and moderate coronavirus disease 2019

(2020) Guang Chen et al.   JOURNAL OF CLINICAL INVESTIGATION

Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

(2020) Yan Zhang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effectiveness of convalescent plasma therapy in severe COVID-19 patients

(2020) Kai Duan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence

(2020) Jeanne Lenzer   BMJ-British Medical Journal

Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion

(2020) Xinyi Xia et al.   BLOOD

Use of convalescent plasma in hospitalized patients with COVID-19: case series

(2020) Livia Hegerova et al.   BLOOD

Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19

(2020) Ling Li et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study

(2020) Hassan Abolghasemi et al.   TRANSFUSION AND APHERESIS SCIENCE

Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies

(2020) Yujun Tang et al.   Frontiers in Immunology

Cytokine Storm: Is it the only major death factor in COVID-19 patients? Coagulation role

(2020) Giuseppe Magro   MEDICAL HYPOTHESES

Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)

(2020) Anup Agarwal et al.   BMJ-British Medical Journal

Ebola virus disease: An emerging and re-emerging viral threat

(2019) Manuel Rojas et al.   JOURNAL OF AUTOIMMUNITY

Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology

(2017) Rudragouda Channappanavar et al.   Seminars in Immunopathology

Immune suppressive properties of artemisinin family drugs

(2016) Lifei Hou et al.   PHARMACOLOGY & THERAPEUTICS

Plasma therapy against infectious pathogens, as of yesterday, today and tomorrow

(2016) O. Garraud et al.   TRANSFUSION CLINIQUE ET BIOLOGIQUE

Intravenous immunoglobulin in neurology—mode of action and clinical efficacy

(2015) Jan D. Lünemann et al.   Nature Reviews Neurology

The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis

(2014) John Mair-Jenkins et al.   JOURNAL OF INFECTIOUS DISEASES

Hyperimmune IV Immunoglobulin Treatment

(2013) Ivan F.N. Hung et al.   CHEST

Plasma components: properties, differences, and uses

(2012) Richard John Benjamin et al.   TRANSFUSION

Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection

(2011) I. F. Hung et al.   CLINICAL INFECTIOUS DISEASES